RGA Stock Recent News

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Reinsurance Group (RGA) have what it takes?

Reinsurance Group of America, Incorporated (NYSE:RGA ) Q2 2025 Earnings Conference Call August 1, 2025 10:00 AM ET Company Participants Axel Philippe Alain Andre - Executive VP & CFO J. Jeffrey Hopson - Senior Vice President of Investor Relations Jonathan William Porter - Executive VP & Global Chief Risk Officer Tony Cheng - President, CEO & Director Conference Call Participants Elyse Beth Greenspan - Wells Fargo Securities, LLC, Research Division Jamminder Singh Bhullar - JPMorgan Chase & Co, Research Division Joel Robert Hurwitz - Dowling & Partners Securities, LLC John Bakewell Barnidge - Piper Sandler & Co., Research Division Michael Augustus Ward - UBS Investment Bank, Research Division Ryan Joel Krueger - Keefe, Bruyette, & Woods, Inc., Research Division Suneet Laxman L.

While the top- and bottom-line numbers for Reinsurance Group (RGA) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Reinsurance Group (RGA) came out with quarterly earnings of $4.72 per share, missing the Zacks Consensus Estimate of $5.58 per share. This compares to earnings of $5.48 per share a year ago.

Reinsurance Group of America, Incorporated's recent quarters show volatile earnings and underwhelming returns, raising concerns about aggressive growth and capital allocation strategy. The EQH megadeal is risky, dilutive to ROE until 2027, and management credibility is on the line to achieve ambitious targets. Despite a high-quality investment portfolio and modest dividend growth, leverage is rising, and deal economics look increasingly questionable.

ST. LOUIS--(BUSINESS WIRE)--Reinsurance Group of America, Incorporated (NYSE: RGA), a leading global provider of life and health reinsurance, reported second quarter net income available to RGA shareholders of $180 million, or $2.70 per diluted share, compared with $203 million, or $3.03 per diluted share, in the prior-year quarter. Adjusted operating income and adjusted operating income, excluding notable items, for the second quarter totaled $315 million, or $4.72 per diluted share, compared.

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Reinsurance Group (RGA), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.

Despite a greedy market, we've found three quality stocks - NVO, RGA, and CP - offering strong value, growth, and reliable dividends. Novo Nordisk leads obesity treatment with strong GLP-1 drugs, a robust pipeline, and a 3.1% yield, trading well below historical P/E. Reinsurance Group of America is an undervalued, financially sound dividend grower with global reach and double-digit earnings growth potential.

Reinsurance Group (RGA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.